Source link : https://www.newshealth.biz/health-news/promise-for-car-t-cell-therapies-in-solid-tumors/
Chimeric antigen receptor (CAR) T-cell therapy has shown efficacy in blood cancers — with six CAR T-cell products now approved by the US Food and Drug Administration (FDA) to treat six hematologic malignancies. For solid tumors, however, the efficacy of CAR T-cell treatments has been limited and progress “more incremental,” Christian Hinrichs, MD, with Rutgers […]
Author : News Health
Publish date : 2025-02-10 11:59:02
Copyright for syndicated content belongs to the linked Source.